BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30970208)

  • 1. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri.
    Rajendran K; Anwar A; Khan NA; Shah MR; Siddiqui R
    ACS Chem Neurosci; 2019 Jun; 10(6):2692-2696. PubMed ID: 30970208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
    Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
    ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleic Acid Coated Silver Nanoparticles Showed Better
    Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
    Rajendran K; Anwar A; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2017 Dec; 8(12):2626-2630. PubMed ID: 29206032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
    Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
    ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Terpenes Inhibit the Cytopathogenicity of
    Rajendran K; Ahmed U; Meunier AC; Shaikh MF; Siddiqui R; Anwar A
    ACS Chem Neurosci; 2023 Dec; 14(23):4105-4114. PubMed ID: 37983556
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
    Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
    Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Growth Rates and
    Russell AC; Kyle DE
    Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Amoebic Meningoencephalitis by
    Güémez A; García E
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
    [No Abstract]   [Full Text] [Related]  

  • 10. Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
    Akbar N; Hussain K; Khalid M; Siddiqui R; Shah MR; Khan NA
    J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37024269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
    Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
    Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
    Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
    PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold Nanoparticle-Conjugated Cinnamic Acid Exhibits Antiacanthamoebic and Antibacterial Properties.
    Anwar A; Siddiqui R; Shah MR; Khan NA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967024
    [No Abstract]   [Full Text] [Related]  

  • 14. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
    Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
    [No Abstract]   [Full Text] [Related]  

  • 15. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.
    Rice CA; Colon BL; Alp M; Göker H; Boykin DW; Kyle DE
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2037-44. PubMed ID: 25605363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
    Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
    Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Anti-Infective Value of Inuloxin A Isolated from
    Zeouk I; Sifaoui I; Rizo-Liendo A; Arberas-Jiménez I; Reyes-Batlle M; L Bazzocchi I; Bekhti K; E Piñero J; Jiménez IA; Lorenzo-Morales J
    ACS Chem Neurosci; 2021 Jan; 12(1):195-202. PubMed ID: 33296597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
    Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
    Peroutka-Bigus N; Bellaire BH
    J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
    Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.